Shah Prem S 4

Accession 0001127602-23-012254

CIK 0000064803other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:36 PM ET

Size

20.8 KB

Accession

0001127602-23-012254

Form 4

Period: 2023-04-01

EVP and Group President

Transactions

Award
Stock Option
2023-04-01$74.31/sh+89,073$6,619,015→ 89,073 total
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (89,073 underlying)
Tax Payment
Common Stock
2023-04-01$74.31/sh−3,221$239,353→ 49,364.32 total

Holdings

Common Stock (pep)
4,520.566
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (28,596 underlying)
28,596
Common Stock (Restricted)
29,649
Stock Unit (deferred)
7,758.851
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (2,935 underlying)
2,935
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (9,469 underlying)
9,469
ESOP Common Stock
4,667.202
Phantom Stock Credits
Exercise: $1.00→ Common Stock (12,232.532 underlying)
12,232.532
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (846 underlying)
846
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (28,723 underlying)
28,723
Stock Option
Exercise: $75.24From: 2021-08-31Exp: 2028-08-31→ Common Stock (26,580 underlying)
26,580
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (41,580 underlying)
41,580

Footnotes (12)

[F1]Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
[F10]Option became exercisable in three equal installments commencing 04/01/2022.
[F11]Option became exercisable in four equal installments, commencing 4/1/2023.
[F12]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
[F2]Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
[F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F5]Option became exercisable in four equal installments commencing 04/01/2017.
[F6]Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
[F7]Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
[F8]Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
[F9]Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.

Documents

1 file

CVS HEALTH Corp

CIK 0000064803

Entity typeother